Create a free research account to view current pricing and place an order.
Mechanism of action
Adipotide is a pro-apoptotic peptidomimetic targeting vascular markers associated with white adipose tissue in preclinical models. Its proposed mechanism involves selective disruption of adipose vasculature and downstream adipocyte loss.
Half-life & pharmacokinetics
Half-life: Not standardized; preclinical context.
Human PK is not standardized and formal clinical-use parameters are not established. Treat as exploratory and high-caution research context.
Research dosing reference
Research dosing is not standardized; conservative low exposure is recommended pending protocol review.
Dose interpretation (U-100 units)
| Target dose | U-100 units |
|---|---|
| 250 mcg | 10 units |
| 500 mcg | 20 units |
Units are concentration-specific - confirm against your actual reconstitution volume.
Reconstitution & concentration
| Vial | Preferred reconstitution | Final concentration |
|---|---|---|
| 5 mg | 2 mL BAC Water | 0.025 mg/unit |
Injection timing
Use only in tightly controlled exploratory contexts. Timing should remain consistent to preserve interpretation.
Beginner escalation
No standardized clinical escalation exists. Any progression should be conservative and review-driven.
Side-effect mitigation
High-caution compound; monitor systemic tolerance, appetite, fatigue, injection response, renal stress signals, and unexpected adverse effects.
Stack compatibility
Avoid stacking with aggressive metabolic or appetite suppressive agents during early evaluation.
Storage & stability
Lyophilized: refrigerated or controlled cool storage. Reconstituted: refrigerated, protected from heat/light, and handled aseptically.
Protocol duration & reassessment
High-caution investigational exposure only. Use short, tightly defined courses with extended reassessment intervals; do not repeat until tolerance, objective markers, and risk/benefit are reviewed.
Frequently asked questions
What is Adipotide and how does it work?
Adipotide is a pro-apoptotic peptidomimetic targeting vascular markers associated with white adipose tissue in preclinical models. Its proposed mechanism involves selective disruption of adipose vasculature and downstream adipocyte loss.
What is the half-life of Adipotide?
Adipotide: Not standardized; preclinical context. Human PK is not standardized and formal clinical-use parameters are not established. Treat as exploratory and high-caution research context.
How is Adipotide reconstituted for research?
Preferred reconstitution for the 5 mg vial is 2 mL BAC Water, giving 0.025 mg/unit. Always confirm concentration math before any use. Research use only.
Is Adipotide FDA approved?
No. Adipotide is an investigational research-use-only compound - not for human or animal consumption and not FDA approved.
All research reference · Research guides
External references: Peptide (Wikipedia) · U.S. Food and Drug Administration